{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:06:26Z","timestamp":1787166386302,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.urology.2017.12.016","type":"journal-article","created":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T13:23:28Z","timestamp":1514899408000},"page":"224-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Initial Assessment of the Efficacy of Irreversible Electroporation in the Focal Treatment of Localized Renal Cell Carcinoma With Delayed-interval Kidney Tumor Resection (Irreversible Electroporation of Kidney Tumors Before Partial Nephrectomy [IRENE] Trial\u2014An Ablate-and-Resect Pilot Study)"],"prefix":"10.1016","volume":"114","author":[{"given":"Johann J.","family":"Wendler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Pech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Fischbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"J\u00fcrgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Friebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Baumunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Porsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Blaschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Schindele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Siedentopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Ricke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schostak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"K\u00f6llermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe B.","family":"Liehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2017.12.016_bib0010","author":"Ljungberg"},{"key":"10.1016\/j.urology.2017.12.016_bib0015","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/MOU.0000000000000306","article-title":"Update on ablative therapies of renal tumors","volume":"26","author":"D'Andrea","year":"2016","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.urology.2017.12.016_bib0020","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s00120-016-0075-8","article-title":"[Focal therapy for small renal masses: observation, ablation or surgery]","volume":"55","author":"Wendler","year":"2016","journal-title":"Urologe A"},{"key":"10.1016\/j.urology.2017.12.016_bib0025","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.eururo.2015.10.004","article-title":"Excision versus ablation in renal cancer: optimising outcome and minimising risk","volume":"69","author":"Hayes","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2017.12.016_bib0030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.eururo.2014.07.021","article-title":"Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses","volume":"67","author":"Thompson","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2017.12.016_bib0035","series-title":"Irreversible Electroporation","isbn-type":"print","first-page":"328","author":"Rubinsky","year":"2009","ISBN":"https:\/\/id.crossref.org\/isbn\/3642054196"},{"key":"10.1016\/j.urology.2017.12.016_bib0040","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00270-011-0187-x","article-title":"Angiography in the isolated perfused kidney: radiological evaluation of vascular protection in tissue ablation by nonthermal irreversible electroporation","volume":"35","author":"Wendler","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.urology.2017.12.016_bib0045","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00270-011-0257-0","article-title":"Urinary tract effects after multifocal nonthermal irreversible electroporation of the kidney: acute and chronic monitoring by magnetic resonance imaging, intravenous urography and urinary cytology","volume":"35","author":"Wendler","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.urology.2017.12.016_bib0050","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00270-012-0452-7","article-title":"Short- and mid-term effects of irreversible electroporation on normal renal tissue: an animal model","volume":"36","author":"Wendler","year":"2013","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.urology.2017.12.016_bib0055","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00270-010-9964-1","article-title":"Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study","volume":"34","author":"Pech","year":"2011","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.urology.2017.12.016_bib0060","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jvir.2010.12.014","article-title":"Investigation of the safety of irreversible electroporation in humans","volume":"22","author":"Thomson","year":"2011","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.urology.2017.12.016_bib0065","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00270-015-1200-6","article-title":"First delayed resection findings after irreversible electroporation (IRE) of human localised renal cell carcinoma (RCC) in the IRENE Pilot Phase 2a Trial","volume":"39","author":"Wendler","year":"2016","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.urology.2017.12.016_bib0070","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jvir.2016.03.044","article-title":"Irreversible electroporation for surgical renal masses in solitary kidneys: short-term interventional and functional outcome","volume":"27","author":"Diehl","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.urology.2017.12.016_bib0075","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00345-017-2025-5","article-title":"Irreversible electroporation of small renal masses: suboptimal oncologic efficacy in an early series","volume":"35","author":"Canvasser","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2017.12.016_bib0080","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cct.2015.05.002","article-title":"A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial)","volume":"43","author":"Wendler","year":"2015","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.urology.2017.12.016_bib0085","article-title":"Upper-urinary-tract effects after irreversible electroporation (IRE) of human localised renal-cell carcinoma (RCC) in the IRENE pilot phase 2a ablate-and-resect study","author":"Wendler","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.urology.2017.12.016_bib0090","series-title":"Manual NanoKnife_ System Procedure & Trouble Shouting Guide. Software Version 2.2.0. AngioDynamics","first-page":"1","year":"2011"},{"key":"10.1016\/j.urology.2017.12.016_bib0095","doi-asserted-by":"crossref","first-page":"54","DOI":"10.12659\/PJR.896034","article-title":"Irreversible electroporation (IRE): standardization of terminology and reporting criteria for analysis and comparison","volume":"81","author":"Wendler","year":"2016","journal-title":"Pol J Radiol"},{"key":"10.1016\/j.urology.2017.12.016_bib0100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.urology.2017.12.016_bib0105","series-title":"TNM Classification of Malignant Tumours","author":"Brierley","year":"2017"},{"key":"10.1016\/j.urology.2017.12.016_bib0110","series-title":"TNM Supplement. A Commentary on Uniform Use","author":"Wittekind","year":"2012"},{"key":"10.1016\/j.urology.2017.12.016_bib0115","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/S1569-9056(17)30129-X","article-title":"Initial assessment of clinical feasibility, safety and efficacy of NanoKnife irreversible electroporation (IRE) in the focal treatment of localized renal cell carcinoma (RCC) with delayed interval tumor resection (IRENE trial)","volume":"16","author":"Wendler","year":"2017","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.urology.2017.12.016_bib0120","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.jvir.2014.08.027","article-title":"Image-guided tumor ablation: standardization of terminology and reporting criteria\u2014a 10-year update","volume":"25","author":"Dupuy","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.urology.2017.12.016_bib0125","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.jvir.2014.09.005","article-title":"Image-guided tumor ablation: standardization of terminology and reporting criteria\u2013a 10-year update: supplement to the consensus document","volume":"25","author":"Ahmed","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.urology.2017.12.016_bib0130","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s00345-016-1828-0","article-title":"Follow-up after focal therapy in renal masses: an international multidisciplinary Delphi consensus project","volume":"34","author":"Zondervan","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2017.12.016_bib0135","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.diii.2017.07.007","article-title":"Irreversible electroporation and thermal ablation of tumors in the liver, lung, kidney and bone: what are the differences?","volume":"98","author":"Vroomen","year":"2017","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.urology.2017.12.016_bib0140","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0022-5347(05)65159-2","article-title":"The uncertainty of radio frequency treatment of renal cell carcinoma: findings at immediate and delayed nephrectomy","volume":"167","author":"Rendon","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.12.016_bib0145","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1464-410X.2007.06769.x","article-title":"\u201cSkipping\u201d is still a problem with radiofrequency ablation of small renal tumours","volume":"99","author":"Klingler","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2017.12.016_bib0150","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.crad.2017.03.007","article-title":"Image-guided ablation of renal cell carcinoma","volume":"72","author":"Wah","year":"2017","journal-title":"Clin Radiol"},{"key":"10.1016\/j.urology.2017.12.016_bib0155","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jvir.2015.02.001","article-title":"Factors associated with short-term local recurrence of liver cancer after percutaneous ablation using irreversible electroporation: a prospective single-center study","volume":"26","author":"Niessen","year":"2015","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.urology.2017.12.016_bib0160","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/1477-7819-12-252","article-title":"Positive surgical margins in nephron-sparing surgery: risk factors and therapeutic consequences","volume":"12","author":"Steinestel","year":"2014","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.urology.2017.12.016_bib0165","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.eururo.2011.11.028","article-title":"Positive surgical margins after nephron-sparing surgery","volume":"61","author":"Marszalek","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2017.12.016_bib0170","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.eururo.2011.03.030","article-title":"Active surveillance of small renal masses: progression patterns of early stage kidney cancer","volume":"60","author":"Jewett","year":"2011","journal-title":"Eur Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042951731333X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042951731333X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T13:36:28Z","timestamp":1530279388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009042951731333X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":33,"alternative-id":["S009042951731333X"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2017.12.016","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Initial Assessment of the Efficacy of Irreversible Electroporation in the Focal Treatment of Localized Renal Cell Carcinoma With Delayed-interval Kidney Tumor Resection (Irreversible Electroporation of Kidney Tumors Before Partial Nephrectomy [IRENE] Trial\u2014An Ablate-and-Resect Pilot Study)","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2017.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}